Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recognizing coccidioidomycosis

A S Bayer

    American Family Physician
    |September 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Primary pulmonary coccidioidomycosis typically resolves on its own. Antifungal therapy is indicated if symptoms persist, sputum cultures remain positive, or specific diagnostic tests suggest disease progression.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.

    Antimicrobial agents and chemotherapy·2017
    Same author

    Antimicrobial peptides versus invasive infections.

    Current topics in microbiology and immunology·2006
    Same author

    Low-level resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein 1 in vitro associated with qacA gene carriage is independent of multidrug efflux pump activity.

    Antimicrobial agents and chemotherapy·2006
    Same author

    Linezolid: a new antibiotic.

    Drugs of today (Barcelona, Spain : 1998)·2003
    Same author

    New approaches to the prevention and treatment of severe S. aureus infections.

    Drugs of today (Barcelona, Spain : 1998)·2003
    Same author

    [Culture-negative endocarditis: etiology, diagnosis, management and therapy].

    Herz·2001
    Same journal

    For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

    American family physician·2026
    Same journal

    Nausea and Vomiting During Pregnancy.

    American family physician·2026
    Same journal

    Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

    American family physician·2026
    Same journal

    Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

    American family physician·2026
    Same journal

    Overscreening Leads to Overdiagnosis of MASLD.

    American family physician·2026
    Same journal

    Type 2 Diabetes: Outpatient Insulin Management.

    American family physician·2026
    See all related articles

    Area of Science:

    • Infectious Diseases
    • Pulmonology
    • Mycology

    Background:

    • Primary pulmonary coccidioidomycosis is a common fungal infection.
    • The disease often presents with self-limited symptoms like fever, cough, and chest pain.
    • Hypersensitivity reactions, including skin lesions and polyserositis, can occur.

    Purpose of the Study:

    • To outline the typical presentation and course of primary pulmonary coccidioidomycosis.
    • To identify indicators for potential disease progression or dissemination.
    • To establish criteria for initiating antifungal therapy.

    Main Methods:

    • Clinical observation and diagnostic criteria were used.
    • Symptom duration, sputum culture results, and serological tests (complement fixation titers) were assessed.

    Related Experiment Videos

  • Skin test reactivity was evaluated in conjunction with serology.

    • Main Results:

    • Most cases of pulmonary coccidioidomycosis are self-limiting.
    • Persistent symptoms (over 8 weeks), positive sputum cultures, or specific serological findings suggest complications.
    • High serum complement-fixation titers with negative skin tests can indicate progression.

    Conclusions:

    • Early recognition of persistent or progressive disease is crucial.
    • Specific clinical and laboratory findings guide the decision for antifungal treatment.
    • Timely intervention can manage complicated coccidioidomycosis cases.